Last reviewed · How we verify

NCT05754827

RDW to Platlet Count Ratio in CKD Patients

Status unknown Last updated 16 March 2023
What this trial tests

trial testing RDW to platlet count ratio in Cardiovascular Complication in 100 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
22 February 2024
22 March 2024

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 April 2023
Primary completion22 February 2024
Estimated completion22 March 2024

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

18 and older, any sex, with Cardiovascular Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to determine Red blood cell distribution width to platelet count ratio as a predictor of cardiovascular complications in CKD patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Complication

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05754827.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing